18283-Urothelial Cancer-ALL-56

Urothelial Cancer

A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer (IMMU-132-06)

  • Details

ClinicalTrials.gov ID: NCT03547973
Diagnosis Type: ALL
USOR Number:

  • Address

4715 Arapahoe Avenue
Boulder, CO 80303
P: (303) 385-2068

Search by practice name, trial titles, indicators and specific disease types.

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.